Amazon appoints leader of new pharmacy business

Amy Baxter | | Health Exec | Management

Months after acquiring online pharmacy PillPack for approximately $1 billion, Amazon has appointed a 14-year veteran with the company to lead its new pharmacy business, CNBC reported. Nader Kabbani has been named vice president of consumables, special projects.

The PillPack team reports to Kabbani, CNBC reported. Kabbani previously worked on Amazon’s Kindle platform and was vice president in the company’s Flex and logistics businesses. The pharmacy business represents a significant opportunity for Amazon as it continues to branch into new industries, particularly healthcare.

Amazon continues its push into the pharmacy business, and has appointed a 14-ye…

“With PillPack, Amazon is poised to take a slice of the growing home delivery market, though it could also potentially incorporate retail pharmacy offerings at Whole Foods locations, after buying the upscale grocery chain for more than $13 billion in 2017,” CNBC reported.

Amazon’s impact on the space has already been apparent, with stocks of other major pharmacies dropping at the time the company acquired PillPack.

See the full story below:

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

More than 1,000 hospitals earn $700M opioid crisis judgment
CEO of Amazon’s One Medical steps down
Nonprofit academic hospital receives criticism after running Super Bowl ad
Hospital delays opening after vandals sledgehammer holes into walls
Cigna announces changes to improve prior authorization, customer satisfaction
UnitedHealthcare in dispute with maternity practice over $1M in claims

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.